Chilian W M, Layne S M, Eastham C L, Marcus M L
Department of Medical Physiology, Texas A&M University College of Medicine, College Station 77843.
Circ Res. 1989 Feb;64(2):376-88. doi: 10.1161/01.res.64.2.376.
We tested the hypothesis that humoral or neurogenic alpha-adrenergic activation in the coronary circulation would produce heterogeneous vascular reactions. To accomplish this, the epicardial coronary microcirculation was viewed through an intravital microscope using stroboscopic epi-illumination. Microvascular diameters were measured under control conditions during beta-adrenergic blockade (propranolol 1 mg/kg) and beta-adrenergic blockade with pacing; during coronary alpha-adrenergic activation in the presence of beta-adrenergic blockade with three doses of norepinephrine infusion (0.1, 0.5, and 1.0-2.0 micrograms/kg/min) or three frequencies of bilateral stellate nerve stimulation (2, 10, and 20 Hz); and during combined alpha- and beta-adrenergic blockade (phentolamine 2 mg/kg and propranolol 1 mg/kg). Diameters of both arterial and venous vessels were reduced during beta-adrenergic blockade but returned back to baseline with pacing. At the lowest level of norepinephrine infusion or frequency of bilateral stellate stimulation, microvessel constriction was not observed. At the higher doses of norepinephrine a -5.1 +/- 0.9% (1.0-2.0 micrograms/kg/min) and a -4.0 +/- 1.1% (0.5 micrograms/kg/min) decrease in diameter of arterial vessels greater than 100 microns in diameter were observed (p less than 0.05). At 10 Hz and 20 Hz of stellate stimulation, diameter decreased by -4.8 +/- 1.9% and -4.4 +/- 2.1%, respectively, in these relatively large vessels. Small coronary arterioles (less than 100 microns diameter) dilated significantly during the highest levels of nerve stimulation (9.2 +/- 2.5% increase in diameter) or infusion rate of norepinephrine (13.6 +/- 2.7% increase in diameter) (p less than 0.05). These constrictor and dilator responses were abolished following combined alpha- and beta-adrenergic blockade. Norepinephrine infusion resulted in a decrease in diameter of coronary veins and venules (7.2 +/- 1.3%) (p less than 0.05), whereas stellate stimulation did not significantly reduce venous and venular diameters. In summary, the coronary venous and venular vasculature responds to alpha-adrenergic activation from circulating norepinephrine but is not affected by stellate stimulation. In contrast, stellate stimulation and norepinephrine infusion elicit similar responses in the coronary arterial and arteriolar microvasculature. Constriction occurs in vessels greater than 100 microns in diameter, whereas dilation predominates in vessels less than 100 microns in diameter. Such heterogeneous arterial responses would undoubtedly result in a redistribution of coronary vascular resistance toward larger coronary arteries and arterioles.
我们检验了冠状动脉循环中体液性或神经性α-肾上腺素能激活会产生异质性血管反应这一假说。为实现此目的,通过使用频闪落射照明的活体显微镜观察心外膜冠状动脉微循环。在β-肾上腺素能阻断(普萘洛尔1 mg/kg)及β-肾上腺素能阻断并起搏的对照条件下测量微血管直径;在β-肾上腺素能阻断存在时,通过输注三种剂量的去甲肾上腺素(0.1、0.5及1.0 - 2.0微克/千克/分钟)或三种频率的双侧星状神经刺激(2、10及20赫兹)进行冠状动脉α-肾上腺素能激活时测量微血管直径;以及在α-和β-肾上腺素能联合阻断(酚妥拉明2 mg/kg和普萘洛尔1 mg/kg)时测量微血管直径。在β-肾上腺素能阻断期间,动脉和静脉血管直径均减小,但起搏后恢复至基线水平。在最低剂量的去甲肾上腺素输注或双侧星状神经刺激频率下,未观察到微血管收缩。在较高剂量的去甲肾上腺素时,观察到直径大于100微米的动脉血管直径分别减小-5.1±0.9%(1.0 - 2.0微克/千克/分钟)和-4.0±1.1%(0.5微克/千克/分钟)(p<0.05)。在星状神经刺激频率为10赫兹和20赫兹时,这些相对较大血管的直径分别减小-4.8±1.9%和-4.4±2.1%。在最高水平的神经刺激(直径增加9.2±2.5%)或去甲肾上腺素输注速率(直径增加13.6±2.7%)时,小冠状动脉小动脉(直径小于100微米)显著扩张(p<0.05)。这些收缩和扩张反应在α-和β-肾上腺素能联合阻断后消失。去甲肾上腺素输注导致冠状静脉和小静脉直径减小(7.2±1.3%)(p<0.05),而星状神经刺激未显著降低静脉和小静脉直径。总之,冠状静脉和小静脉血管系统对循环中的去甲肾上腺素引起的α-肾上腺素能激活有反应,但不受星状神经刺激影响。相比之下,星状神经刺激和去甲肾上腺素输注在冠状动脉和小动脉微血管系统中引发相似反应。直径大于100微米的血管发生收缩,而直径小于100微米的血管以扩张为主。这种异质性动脉反应无疑会导致冠状动脉阻力重新分布至较大的冠状动脉和小动脉。